The obesity-related increased EPO levels are restored after VLCKD intervention at the time of maximum ketosis, suggesting a potential role of the nutritional ketosis induced by the VLCKD. The gene discussed is EPO; the disease is obesity due to melanocortin 4 receptor deficiency.